Designing development strategies that support earlier intervention and improve long-term outcomes
Gaining practical insights into how to optimize trial design, patient recruitment, and the use of real-world endpoints
Addressing the complexities of small, heterogeneous pediatric populations to enhance study feasibility and success
Engaging regulators effectively and plan for how pediatric medicines are evaluated differently—especially for cell and gene therapies and earlier treatment approaches